After being all-but written off a year ago, AstraZeneca’s anifrolumab has been reborn with new data that suggest it could help to end a drought in treatments for autoimmune disease systemic ...

Saphnelo (anifrolumab) is the first biologic drug for SLE to be approved in Europe that is not restricted to patients with a high degree of disease activity, according to AZ, which also notes it ...

Figure 1. TNFSF and receptor-ligand complex formation. The structure of TNFSF (light purple) in its unbound state (left), followed by its binding to the TNFSF receptor (green, blue, and pink) (middle) ...